BMI1 and medulloblastoma: miR-128a increases intracellular reactive oxygen species levels by targeting Bmi-1, which inhibits the growth of medulloblastoma cells (138) and miR-218 inhibits cell proliferation and cell cycle progression and promotes apoptosis by downregulating Bmi-1 in colorectal cancer cells (139).